In Florida overlooking the Intercoastal Waterway..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The converters are in charge.. If someone takes the time to read the latest report they will see that some of the preferred are converted.. When it gets lower they will convert the rest IMO,, and then the P&D comes..
If ACGX did a 1 for 1000 reverse it would have 16 million fully diluted share outstanding ad on that basis it would have less than $0.01 EPS this first qtr.. It's price would have to equal $1.50.. That would be a lot to pay for a stock with earnings down on it's historical largest qtr. Projections/or statements that the President would not sell before $0.10 of over on today's cap are insane because the price of the stock would have to attain a price of over $99.00 per share .. That ain't going to happen.. hank
KLYG.. $0.07... 3 weeks and no trades.. Where did all the sellers go..?? This is an investment and the furthest thing you will find from a trading stock,, but you are as anyone else are free to hit the bid which at this time is equal to all shares traded in the past month.
But again thanks for your comments since you seem the only person other than myself that posts with regularity on this board and offers at a least another view than mine well founded on your interpretation of the markets.. hank
ACGX.. $0.0016.. If that were the real reason to own any stock then there would be no stock market at all and the reason that most company increase shares is to create capitol for the operations by the company..
Company's always would rather use any line to pay back monies owed rather than issue toxic financing deals that allow the debt to convert and pound the stock to a worthless value because ever share they sell gives them the opp. to replace it a discount which in the case of ACGX is 30%.. The lower it goes the more shares they get and the cycle continues.
.
Sadly when they were earning $0.12 per share jus a little over 2 years ago and had but 8.5 million shares outstanding they could of paid off all their debt with cash avil. and existing bank lines at favorable interest rates.. Why didn't they..??
Their answer is that they wanted to conserve cash for business purposes,, but were ok diluting existing shareholders to a value of 0.0001% of their origional vested interest in the company...
ACGX $0.0015..The first Qtr of each year ACGX usually reports the the highest earnings ..But this Qtr. it appears Looks like all items including sales were down.. Am I missing something why the last report was good.... Also no shares or money exchanged were outlined by any merger or venture with any company.. So what was paid for their latest acquisition..???? Why is the ask always stacked after a PR..?? And why when they show their latest financials do they now show as any other company a comparison to the same period of the preceding year.. That alone is a red flag.. The below had to be dug out of the latest filing.. hank
Item 12: Financial information for the issuer’s most recent Quarter:
The financial statements ending March 31, 2015 are posted on www.OTCmarkets.com the Pink Sheets website and
incorporated in this disclosure statement by reference.
The information includes:
Balance sheets
Statements of Income
Statements of cash flows
And Shareholder Equity Statement
Revenues for the quarter ending March 31, 2015 (“Q1 2015”) were $3,058,662 compared with $3,299,009 for the quarter ending March 31, 2014 (“Q1 2014”). That is a decrease of $240,348 for the quarter or a 7.3% decrease.
Gross Profits for the quarter was $762,672 for (“Q1 2015”) compared to $890,474 for (“Q1 2014”). That is a decrease of $127,802 or a 14.4% decrease. Incomes were $112,222 for (“Q1 2015”) compared to $326,796 for (“Q1 2014”). That is a decrease of $214,574.
The total assets of the Alliance Creative Group as of 3/31/15 were $6,059,262 compared to 3/31/14 when they were $6,469,829.
The total outstanding common shares as of March 31, 2015 were 749,403,740 with 649,082,765 of those shares in the float.
See detailed Financial Statement for March 31, 2015 on the following pages
KLEG.. $.07.. I got back from my visit at KLYG and was very impressed. It will take a couple of days to put it all together and post on the Info portion of this board.. Follow my posts on Hank's Trading / Value Micro Caps for bits of Info as assemble the thoughts of today.. hank
There never has been a negative comment by me on this company..
In fact I posted several times it's a nice little company the size of the Halmark store at your local mall in revenues.. But it's policy of converting shares for debt rather than paying them off has left shareholders with a diminishing % of the equity they own.. Since ACGX is controlled by the preferred insiders have no fear of loosing control as long as the own one share..
The problem is not with the company but the way the company is used in PR's to promote the stock in order for the converter's to sell and dilute ACGX just as it predecessor did..
Now we have another large converter in the wings that is STLK which ACGX owned and sold.. I never figured if they sold the shell w/o assets how they now owe them $275K but since they don't do audits or announce thru filings when they dispose or acquire assets or companies we just have to use the info they give.. Really..???
STLK trades 100's of million of shares weekly @$0.0001and seems on it's last breath of corporate life so I'm sure the shares for the $275K would come in handy now... $275K = 275 Million shares after the discount.. hank
I will be seeing them tomorrow morning.. Hopefully I can take some pictures.. hank
I feel no different today than I did in this post.. As to moving on,, why should I,, If I just keep one person from losing money I feel gratified.. Also since I mod another board how else would I get posts on it..?? Money is a tool and it has no anger attached.. hank
Sorry but I don't understand but thanks for your comments,, your analysis is always welcomed.. hank
No Not really because the story never changes and even if I look at it just once a week it's like an old soap opera where you can miss weeks and loose any actual story line.. On ACGX the story line has always been dilute,, hold the stock down to reload and blame it on someone else.. hank
It helps the expectations of a more positive report.. I doubt it will show anything other than ACGX because in spite of what they say until there is a filing it's just not a fact..
It's almost like this is a new company after the reverse but,, same company with the same dilution mode.. If they aren't reporting they are diluting.. He said the auth. shares would increase in a short period of time at the last tele. conf. but no word yet.. I doubt you will hear anything before the preferred are converted into 400 million plus shares,, so the lower it goes the more shares they get and then the P&D...
I also notice the stacking of shares on the ask and the low volume.. On day's volume occurs the stacks get sold and in 2 or 3 days they re appear.. Seems down is what they want and down is what they will get.. hank
Geeze,, guys you are getting to get so hard on management.. If looking at the last 100 posts you will realize that only a few names are posting to each other.. Management and friends own the new preferred so why should they buy in the open market when it is them that are/could be selling.. The lower it goes the more they own at a 30% discount to the market..
I actually called three days in a row and was dumped into T. Anthony's mail box.. On the first call I spoke to the production Mgr and he referred me to T. Anthony, thinking I was spending some time in CT. After 3 day's I called the Production Mgr. back asking why I had not heard from T. Anthony and only then did I find he was out of town..
After our conversation he called T.Anthony and then he invited me over to look at the facilities but I elected to wait until I could also see T. Anthony and the facilities at the same time..
So I will be there on Tuesday or Wed. at my choosing.. One reason I did not get a call back from T Anthony right away ( my impression from the questions the production mgr asked ) was because he hates all the slime that call him that first disguise their phone calls as interested investors but are actually PR firms looking for business.. I'm very Optimistic. hank
I'm I CT at present but Management was out for the week do presentations for new business.. Spent some time speaking to some one in production and there were at that time 7 persons busy working at the company.. Will visit next Tuesday or Wed.. hank
So that's were the petting zoo went.. Mabee they used him to get rid of the other toy's that Ron used and billed to the company.. I wonder what happened to the property Ron sold to the company before they moved.. It was funny that when they sold his fab shop property to the company it was no longer good enough for headquarters so they rented a new set of plush offices..
$0.10 before year end and then Goldman will own control and olny then will we se a turn around where DPDW can actually make money.. Because then they will again become a Fab Shop w/o the overhead that supports the lifestyle of management.. hank
ERILF.. $0.12 USD.. Empire Industries Reports 2014 Profit of $6.1 million...
Summary of 2014 annual results
Revenues increased by 20%
up $23.4 million to $141.2 million (from $117.8 million in 2013)
Adjusted EBITDA increased by 27%
up $1.7 million to $8.0 million (from $6.3 million in 2013)
Net Income increased by 39%
up $1.7 million to $6.1 million (from $4.4 million in 2013).
Per Share Net Income (Basic) was $0.024 in 2014 (from $0.02 in 2013)
Backlog of $155 million, up from $93 million at of the Group’s third quarter report;
“I am particularly pleased to announce the financial results for 2014. What was most noticeable in 2014 was the diversity of our profit from our three business units and the strengthening backlog in our media based attractions unit,” said Guy Nelson, CEO of Empire Industries. “There are storm clouds in Western Canada but the strategic investments we have been making over the past few years are starting to pay off and we expect this trend to continue.”
About Empire Industries Ltd.
Empire Industries Ltd. manufactures specialized engineered products and sells these products domestically and in select international export markets. The company has developed, designed and engineered products for the rapidly growing, global, media based attractions market. The company also manufactures and sells hydrovac trucks and also provides steel fabrication & installation services, primarily to the industrial, commercial and infrastructure market in Western Canada. The company also has two key strategic equity partnerships; a 49% ownership of ACE Industrial Services that operates in the oil sands industrial maintenance services market, and a 45% ownership of a Chinese joint venture company in the steel fabrication market in Asia. Empire’s common shares are listed on the TSX Venture Exchange under the symbol EIL.
http://www.empind.com/news/empire-industries-reports-2014-profit-of-61-million
For all filings...http://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00022006
Goldman reduced his shares,, not ADDED...
GOLDMAN CAPITAL MANAGEMENT INC
1,318,000 $ 1,055,000 0.58% 0.94% 20 43,000
ACGX.. $0.0014.. Just a view into the rear view mirror...
Paul Sorkin, CEO of Invicta Group, Appears on Traders Nation TV and Radio Network..
CHICAGO, IL--(Marketwire - December 10, 2009) - Invicta Group, Inc. (http://www.ivitgroup.com) (PINKSHEETS: IVIT) announced today that the CEO Paul Sorkin appeared on TradersNation.com, an internationally syndicated television and radio programming outlet. Mr. Sorkin answered a wide variety of questions regarding Invicta Group, Inc. including its marketing business, acquisitions and increasing revenues. The interview can be viewed here: http://IVITgroup.com/investorrelations.html
Mr. Sorkin stated that the company was likely to have revenues in the range of $15M in 2010. Invicta continues to build out their business organically and through acquisitions of well established companies that have synergy with Invicta's present businesses and plans for growth.
About Invicta Group, Inc.
INVICTA GROUP, Inc. is a full service multimedia management and marketing company. The Invicta Group is a conglomerate with an aggressive sales and marketing team that utilizes shared overhead and resources like office space, technology, administrative employees, legal and accounting services, creative and design tools, and IT solutions. The synergies allow a lower cost of entry into the marketplace and almost instant start up capabilities for new products, services, and clients. Current projects and companies include: Water Tower Surgical Center, STL Graphics, St. Louis Packaging, IMAGE Chicago Magazine, TravelHotLink.com, TicketHotlink.com, IMAGE Mobile Marketing, and the IMAGE Brands. The 8 Main websites are: www.IVITgroup.com, www.WTsurgi.com, www.TravelHotLink.com, www.TicketHotLink.com, www.IMAGEchicago.com, www.IMAGEmobileMarketing.com, www.STLgraphics.com, and www.Stlouispackaging.com
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plan, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Contact Information
Media Contact
info@IVITgroup.com
Investor Relations Contact
1-312-473-5234
info@IVITgroup.com
KLYG.. $0.188 Past RR releases not easily avil.On past posts I have made during the past few years.. for futher DD and Research are shown below.. My gut tells me that 2.5 mil. are/is the current rate of sales for the past 12 mo's trailing.. hank
Hopefully KLYG backoff's from today's spike will happen as I now believe that KLYG is no longer a lottery ticket but has a good possibility of becoming a true Micro-cap growth stock.. I will add on any weakness.. Normally close lipped management has come out with New members to the board that will give it exposure thruout the industry which it serves.. Over a year ago a published letter to a respected Nuerosurgeon Journal was written by a respected Nuerosurgeon that seemed to aid in the validity of its procedures and methods of expertise in cranial bone repair.. The new additions to the board will again further their penetration into this new and exciting field.. This Journal Article is contained in a PR below..
I think that with just a few more Qtr's of continued performance a buyout could very well happen and at the least a ten-bagger from this level.. Continued growth and earnings at this rate could very well place KLYG into the high multiple values given medical device companies..
Personally I think KLYG could be a life changing stock for any that continue to own it.. hank
=============================================================
Kelyniam Announces Record Net Income and Additions to the Board of Directors
GlobeNewswire - Jun 03 09:48 EDT
Alert hits:OTC All /kl
Company Symbols: OTC-PINK:KLYG
Canton, CT, June 3, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc, (OTC: KLYG), a prominent manufacturer of custom cranial implants, today reported that the company generated net income of $71,205 in the first quarter of 2014.
Compared with first quarter 2013, net sales increased 23% from $437,415 to $540,286, as a result of increased market penetration, gross profit moved up from $229,027 to $269,788, and net income swung from a loss of $17,272 to a profit of $71,205. Financials will be provided at www.kelyniam.com. "This is the strongest first quarter in the company's history", stated Tennyson Anthony, President and CEO. "Our progress is encouraging and it suggests there is a lot more room for the company to grow. Furthermore, we are working to increase our gross margins throughout 2014."
In addition, the company is excited to announce that the board has appointed Dr. Mark Smith, a prominent Nuerosurgeon, and Dr. Naveh Levy, a practicing Diagnostic Radiologist, to the board of directors.
Mark V Smith, M.D. is a neurosurgeon with over 20 years of clinical experience. He has also worked as a biomedical engineer. He graduated magna cum laude with a bachelor's degree in Electrical Engineering from the University of Maryland in 1980. After working two years as a biomedical engineer, he was admitted to medical school where he earned a doctorate of medicine at the University of Maryland in 1986. He completed his neurosurgery training at SUNY Upstate University Hospital in Syracuse, New York in 1993. He is also fellowship trained in pituitary surgery and epilepsy surgery. Dr. Smith was as an assistant professor of neurological surgery at SUNY Health Sciences Center in Syracuse, New York from 1994 to 1999 specializing in epilepsy and skull base surgery. In 1999 he started a private practice neurosurgery group in Utica, New York. Dr. Smith has received numerous awards and grants and is published in the fields of neuroanatomy, neurophysiology and neurosurgery.
Naveh Levy, M.D. completed his residency at the Cleveland Clinic in 2008 and an MRI Fellowship in 2009 at Michigan State University. He holds a medical degree from George Washington University School of Medicine in Washington, D.C.
"Kelyniam is in the business of taking raw data, a patient's CT scan, and creating a superior product with intricate details for the surgeon to implant in the patient. These new board members bring the technological acumen to complement both aspects of the business," stated Mr Anthony. "We are excited to have them join us."
=============================================================
Kelyniam Global Inc. Revenues Grow 54% from Prior Year
GlobeNewswire - Apr 07 08:30 EDT
Alert hits:/kl
Company Symbols: OTC-PINK:KLYG
Canton, CT, April 7, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc.(OTC: KLYG), a manufacturer of custom cranial implants, announces preliminary revenue of $1,857,516 for 2013. This represents an increase of 54% vs. sales of $1,206,227 in 2012. The Kelyniam product fit and quick turnaround has captured the attention of surgeons throughout the United States. The revenue increase reflects the continued rollout in many additional hospitals. The company will provide financials on their website, kelyniam.com, when they become available in final form from the Accounting Firm.
President and CEO Tennyson S. Anthony stated: "Although we are showing consistent growth and have become a profitable company in a relatively short time, rest assured we are focused on building a company that has the ability to grow at a much greater rate in the near future. My team and I have been working tirelessly to create a company that has the technology, economic fortitude, and operational efficiency to be the market leader in customized implants. We are just starting to see the fruits of our efforts."
=============================================================
Kelyniam Global Inc. Unveils New Product
Canton, CT, April 2, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. has introduced a new product to the marketplace, the "IFS" (Integrated Fixation System) product. The product is patent pending and provides faster implantation, reduced hardware, cost savings and elimination of mundane tasks during the surgical procedure.
The design team at Kelyniam created this product with the surgeons needs in mind together with the realization of economic sensitivities by the hospitals. They carefully collected feedback and input from a multitude of surgeons and designed the product to make their surgeries more efficient.
Kelyniam will be unveiling the new product at the 82nd Annual AANS (American Association of Neurological Surgeons) meeting April 5-9, 2014 in San Francisco.
The company also expects to report financials for 2013 in the coming weeks.
About Kelyniam Global, Incorporated
Kelyniam Global (Pinksheets: KLYG), Inc. specializes in the use of CAD/CAM technology to provide patient specific custom implants to assist medical professionals by allowing them to operate more effectively, improve patient care, and reduce health care costs by providing the highest quality products available with today's technology. The company is continually researching and developing new products and processes to help patients live more active and productive lives.
===================================================================
KLYG.. $0.1388.. I think it's a table pounder but I need to see one more Qtr.. It's been my lottery ticket for 2 years.. Kelyniam Global Inc. turns profitable during the second quarter of 2013
Canton, CT, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. (OTC: KLYG) ("the company") is pleased to announce that it has posted its first ever quarterly profit, for the quarter ending June 30, 2013. Net income for the second quarter was $6,608. Sales in the second quarter were $593,355, up 35% from $438,415 in the first quarter 2013. Year to date sales were $1,031,770, up 253% from the same period in 2012.
The company continues to deploy capital towards marketing and organic growth, and to build market share as its customized PEEK implants are sold in more hospitals than ever. It has recently negotiated better terms for the DECD note secured last year, with the term of the note changing from 5 years to 10 without any increase in the interest rate.
Kelyniam will be an active participant in the Connecticut Economic Trade Mission to Australia later this week, traveling to both Sydney and Canberra, Australia. President & CEO Tennyson Anthony exclaimed, "While we are pleased with our second quarter performance, it is our goal to be used in all 50 states and internationally as well." He continued, "In fact, our growth is not only focused on geography, but on building on our existing products. The company will be announcing a new product in the months to come, one that we feel will turn heads."
The company will be posting the financial tables on the website www.kelyniam.com
About Kelyniam Global, Incorporated
Kelyniam Global (Pinksheets: KLYG), Inc. specializes in the use of CAD/CAM technology to provide patient specific custom implants to assist medical professionals by allowing them to operate more effectively, improve patient care, and reduce health care costs by providing the highest quality products available with today's technology. The company is continually researching and developing new products and processes to help patients live more active and productive lives.
Please visit our website at www.kelyniam.com for more information.
==========================================
KLYG.. $0.1078.. My LOTTERY TICKET,, It moves on air.. Now meeting projections made last year...
Kelyniam Global Inc. Announces Continued Revenue Growth & Approval to Sell Overseas
Canton, CT, May 30, 2013 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. (OTC: KLYG), a growing company that designs, manufactures, and sells custom cranial/craniofacial implants, announced today its financial results for the year ending December 31, 2012 and also for the first quarter ended March 31, 2013.
Revenues for the year ending December 31, 2012 totaled $1.2 million. 2012 was the first full calendar year the company had manufactured and sold custom cranial implants in the United States. Revenues for the fourth quarter of 2012 were $414,982 up from $382,177 in the third quarter 2012.
First quarter 2013 revenues were a record $437,415, an increase of 207% from $210,635 in the first quarter of 2012. The increase in sales was attributed to continued marketing and promotional efforts across the United States. The first quarter 2013 marks the first time the company has broken even on an accrual basis.
The 2013 year brings the headwind of the medical device tax to the industry. Beginning Jan 2013 and unless Obamacare is repealed; Kelyniam will be liable for a 2.3% tax on all medical device sales.
A further note: Kelyniam is pleased to announce it has recently been approved to sell its custom cranial/craniofacial implants in Kuwait. It anticipates sales to begin in the coming months.
Related unaudited financial tables will be posted on the company's website www.kelyniam.com.
About Kelyniam Global, Incorporated
Kelyniam Global (Pinksheets: KLYG), Inc. specializes in the use of CAD/CAM technology to provide patient specific custom implants to assist medical professionals by allowing them to operate more effectively, improve patient care, and reduce health care costs by providing the highest quality products available with today's technology. The company is continually researching and developing new products and processes to help patients live more active and productive lives.
Please visit our website at www.kelyniam.com for more information.
Source: Kelyniam Global Inc.
2013 GlobeNewswire, Inc.
---------------------------------------------------
Kelyniam Custom Cranial Implants Receive Endorsement From Skull Based Neurosurgeon Dr. Ammirati of The Ohio State University Wexner Medical Center
Canton, CT, Jan. 29, 2013 (GLOBE NEWSWIRE) -- (OTC: KLYG) Kelyniam Custom Cranial Implants, designed to fill the boney void in a patient's skull, have been endorsed by Mario Ammirati, MD, Director of Skull Based Surgery, Stereotactic Radiosurgery and the Dardinger Microneurosurgical Skull Based Laboratory, Wexner Medical Center, at the Ohio State University. This is the first product Dr. Ammirati has ever endorsed.
Dr. Ammirati stated: "As a neurosurgeon specializing in skull based surgery and brain tumors, I am encouraged with the advancements Kelyniam has made in patient customized cranial implants. I am extremely happy with the precision fit and the fast service I receive with every case. Complex cranial defects resulting from trauma or oncologic resection present reconstructive challenges. No matter how complex the defect, Kelyniam's implant design team is very responsive to my needs. They understand the surgical plans and are quick to respond to my design requirements. The end result is a product that fits very well and is quick to implant, thereby reducing O.R. time and providing the patient with excellent aesthetic results."
----------------------------------------
Kelyniam Global Inc. Announces Record Revenues
GlobeNewswire - Jan 15 08:15 EDT
Alert hits:/kl
Company Symbols: OTC-PINK:KLYG
Canton, CT, Jan. 15, 2013 (GLOBE NEWSWIRE) --
Third Quarter
Kelyniam is pleased to announce record quarterly revenues of $382,177 for the third quarter ending September 30th 2012. This represents almost double the product revenue produced in the second quarter 2012. The company continues to penetrate the custom cranial implant marketplace and has sold implants to medical institutions in more than 20 different states. Furthermore, the company has sold the first maxiofacial implants in the fourth quarter as a result of the recent FDA 510k approval in late third quarter.
Fourth Quarter
The debut of Kelyniam maxiofacial implants in the fourth quarter was met with orders. These orders combined with existing custom cranial implant orders propelled revenues to approximately $400,000 for the fourth quarter, exceeding internal expectations of a slow quarter due to multiple holidays and fewer surgeries. Final fourth quarter numbers will be released once a full accounting is complete.
"The final two quarters of the year demonstrate that both the custom cranial and maxiofacial implant markets have capacity for a product of superior design. Management has worked hard to right the ship in 2012 and looks to build on the momentum in 2013" stated President and CEO Tennyson Anthony. "Kelyniam not only has created a product that fills the patient's cranial void, but is filling the void in the marketplace for a timely-delivered well-fitting product."
Upcoming Conference
Kelyniam will be exhibiting once again at the North American Skull Base Society (NASBS) February 15th - 17th, in Miami, FL.
Financial tables can be found on the company's website www.kelyniam.com
About Kelyniam Global, Incorporated
Kelyniam Global (Pinksheets: KLYG), Inc. specializes in the use of CAD/CAM technology to provide patient specific custom implants to assist medical professionals by allowing them to operate more effectively, improve patient care, and reduce health care costs by providing the highest quality products available with today's technology. The company is continually researching and developing new products and processes to help patients live more active and productive lives.
Please visit our website at www.kelyniam.com for more information.
Bought some VASO today again.. I think when ACGX ( a dilution machine ) pukes to $0.0006 it might be good for a pop.. hank
BEST.. From the 2014 10K.. hank
CURRENT LIABILITIES:
Accounts payable
$ 8,968,199 $ 12,003,387
Other payables
18,177,999 11,409,170
Unearned revenue
272,135 4,565,107
Accrued payroll
139,274 122,309
Short-term loans
38,744,022 28,862,794
Long-term loan, currently in default 19,524,000 -
Total current liabilities
85,825,629 56,962,767
Long-term loans
7,321,500 9,822,000
Total liabilities
93,147,129 66,784,767
Commitments and contingencies
BEST.. $0.29.. Their loans are up and 18 Mil. are in default..?? hank
I think we will soon see some selling as the converters want it down so they can reload.. Remember if it trades at $0.001 they buy at $0.0007 or 1,428,571.4 shares for each $1,000.00 of debt..
DPGIF.. $0.593.. It seemed during the past week DPGIF was struggling to stay above $0.60 and with a Rt's offering in the wings I just sold 28888,, 60% of my position @ $0.5931 Ave. If the bid gets above $0.62 I'm gone but will rebuy in the high $0.40's if it happens.. hank
DGI.TO,, DGPIF.. I added 8000 @$0.528 USD.. I sold 25000 in the $0.60 range earlier this month.. Do you have any terms on the RT's offering.. hank
DGPIF .. $0.528.. Any one figured out why it's down so much today..?? Stockhouse board makes mention to what may be a rt's offering but it makes little sense to me.. hank
I don't know what else you call it when a company increases it's shares outstanding have increased from 8.5 Million to 725,000,000 and it's president's conversion basis on his preferred from 400,000,000 to 800,000,000 with just a stroke of the pen w/o any compensation to it's other shareholders.. To compare ACGX rate of dilution to other Company's rate of dilution is not valid and has no basis to the value ACGX .. Any thoughts to the contrary is not any basis to make any investment decisions,, considering the fact that some value ACGX on a value stock basis with growing sales and earnings..
Think about it: shares outstanding have increased from 8.5 Million to 725,000,000 and it's president's conversion basis on his preferred from 400,000,000 to 800,000,000 with just a stroke of the pen w/o any compensation to it's other shareholders in just a few months... hank
Volumes Since the beginning of the year..
09:58 0.0017 25,000*
04/15/2015 0.0017 0
04/14/2015 0.0017 2,274,204
04/13/2015 0.0017 1,391,375
04/10/2015 0.0016 3,036,268
04/09/2015 0.0016 3,814,813
04/08/2015 0.0017 7,877,770
04/07/2015 0.0017 201,390
04/06/2015 0.0017 5,598,058
04/02/2015 0.0017 15,196,610
04/01/2015 0.0013 4,388,481
03/31/2015 0.0013 6,079,791
03/30/2015 0.0014 4,785,528
03/27/2015 0.0016 11,647,230
03/26/2015 0.0015 23,949,960
03/25/2015 0.0015 16,438,700
03/24/2015 0.0022 27,931,600
03/23/2015 0.0025 36,387,590
03/20/2015 0.002 2,971,954
03/19/2015 0.002 7,307,527
03/18/2015 0.0018 30,340,780
03/17/2015 0.0021 250,357
03/16/2015 0.0021 4,772,550
03/13/2015 0.002 840,395
03/12/2015 0.002 1,470,849
03/11/2015 0.0019 481,525
03/10/2015 0.002 3,328,210
03/09/2015 0.002 534,000
03/06/2015 0.00195 2,276,800
03/05/2015 0.002 9,836,386
03/04/2015 0.002 2,131,042
03/03/2015 0.0018 2,940,999
03/02/2015 0.0017 3,454,076
02/27/2015 0.0017 1,713,427
02/26/2015 0.0018 6,382,543
02/25/2015 0.0016 1,088,975
02/24/2015 0.0017 6,427,108
02/23/2015 0.0014 7,325,232
02/20/2015 0.0015 135,000
02/19/2015 0.0015 3,932,171
02/18/2015 0.0017 2,260,750
02/17/2015 0.0017 1,132,480
02/13/2015 0.0017 3,424,500
02/12/2015 0.0016 467,714
02/11/2015 0.0017 131,486
02/10/2015 0.0017 2,228,001
02/09/2015 0.0017 3,819,411
02/06/2015 0.0017 8,316,486
02/05/2015 0.0019 596,011
02/04/2015 0.0019 1,270,969
02/03/2015 0.0019 8,464,572
02/02/2015 0.0019 1,363,849
01/30/2015 0.002 365,529
01/29/2015 0.002 535,000
01/28/2015 0.002 2,092,140
01/27/2015 0.002 1,132,401
01/26/2015 0.002 1,397,967
01/23/2015 0.0021 5,489,076
01/22/2015 0.0022 2,680,000
01/21/2015 0.0023 5,406,600
01/20/2015 0.0024 3,727,817
01/16/2015 0.0021 3,325,600
01/15/2015 0.0024 7,962,303
01/14/2015 0.0024 1,095,500
01/13/2015 0.0023 258,718
01/12/2015 0.0024 755,000
01/09/2015 0.0024 519,125
01/08/2015 0.0025 1,283,000
01/07/2015 0.0024 1,000,000
01/06/2015 0.0025 163,600
01/05/2015 0.0025 197,477
The real reason there is little volume is because the only people that haven't been thru a Sorkin Dilution is what remains on this board.. Others got burned on other named companies and some caught on quickly that this is a dead money stock because of continued dilution.. hank
Sorkin says he built a company from nothing to 100 Million in sales and will do the same here.. Below is from an earlier post I made..
[
KLYG.. I will be at their office in May.. Will report back to the board at that time.. At present all I expect is earnings by the end of this month.. hank
OCLG.. $0.052..Does this require more shares to be sold..??
The time you posted in Jan. KLYG went up 50% the very next day.. Maybe the same will happen again..?? But it really doesn't matter because it will trade at $0.50 or better this year or it will remain dead money.. It's all bout the product and not the charts on this one.. I'll be seeing them in May and report back to the board.. Earnings should be out by the end of next week.. hank
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=109836401
Auth. Share increase,, what ever happened to it.. I guess it will be announced after the preferred shares conversion are all done.. That's the way they did it a few years ago when they had but 8.5 million shares outstanding.. Still no term's on the VINE deal.. Wonder why if they are so transparent.. Did they give cash or a note that converts at 30% discount to the market..?? If I had a company to sell them I'd want at least 50% so I could never be front runned on.. hank
SPIN has spun out of control.. BS starts soon..
Spine Pain Management Reports 2014 Financial Results and Reminds for Conference Call at 4:20 EDT Today
HOUSTON, March 31, 2015 (GLOBE NEWSWIRE) -- Spine Pain Management, Inc. (OTCQB:SPIN), a technology-driven, medical service, device and healthcare solution company servicing the multi-billion dollar spine injury sector, will hold an Investor conference call on Tuesday, March 31, at 4:20 p.m. (EDT) to discuss the Company's financial results for its full year 2014 and provide an update on its business initiatives.
For the year ended December 31, 2014 versus 2013:
We recorded $2,046,977 in net revenues with $980,811 in costs of services and gross profit of $1,066,166 for the year ended December 31, 2014. For the year ended December 31, 2013, we recorded $3,299,928 in net revenues with $1,320,348 in costs of services and gross profit of $1,979,580. Revenue was negatively affected by lower case volume in 2014 due to multiple factors. In January 2014 we made the decision to cease financing centers in Florida and terminated our affiliation with our healthcare provider in the state. This decision was made due to the state's difficult personal injury case environment, coupled with our Florida affiliate's bankruptcy (the bankruptcy court has deemed the previously issued letters of protection we obtained through this affiliate will remain our property and should be unaffected by the bankruptcy). Also in January 2014, we made the decision to discontinue doing business in McAllen, Texas in connection with increased competition in the area. We have no revenue from our Florida or McAllen affiliates for the twelve months ended December 31, 2014.
We recognize revenue by reference to "net revenue," which is gross amounts billed using CPT (Current Procedural Terminology) codes less account discounts that are expected to result when individual cases are ultimately settled. A discount rate of 52%, based on settled patient cases, was used to determine net revenue during 2014 and 2013, respectively. Accordingly, we had gross revenues of $4,239,164 with net revenues of $2,046,977 for the year ended December 31, 2014, versus gross revenues of $6,695,289 with net revenues of $3,299,928 for the year ended December 31, 2013.
Expenses
For the year ended December 31, 2014 versus 2013:
Operating, general and administrative expenses for the year ended December 31, 2014 were $2,493,555 as compared to $2,270,230 for the year ended December 31, 2013. The increase in operating expenses was primarily the result of additional overhead associated with our Quad Video marketing, development, and consulting costs.
Net Income or Loss
For the year ended December 31, 2014 versus 2013:
Net loss for the year ended December 31, 2014 was $1,692,658, or $.09 per share compared to net loss of $626,071, or $.03 per share for the year ended December 31, 2013. Lower revenue, due to closing the Florida and McAllen affiliates, coupled with additional personnel to develop and market the Quad Video Halo, resulted in net loss increasing in 2014 from 2013.
During the year ended December 31, 2014, our operations focused on continued development of our spine injury diagnostic business, coupled with the commercial development of our Quad Video Halo for sale to healthcare providers. We incurred charges in re-designing the equipment plus marketing costs for personnel. We also incurred costs in preparing our warehouse for testing of our equipment. In 2014, the operating, general and administrative costs pertaining to the Quad Video Halo totaled $405,008.
Major Developments and Milestones
1,703 Cases Settled to date with cash received surpassing $11 million; leaving 2,414 cases already funded awaiting Settlement.
To maximize potential Shareholder Value, established our patent pending, Quad Video HALO (QVH) in a wholly owned subsidiary and appointed David Spencer, lead development Consultant as President of the new subsidiary.
Opened a Development, Assembly and Warehouse Facility for QVH in Houston, Texas.
Retained Cooper Consulting (CCS), a 30 year old Houston based firm specializing in advising and assisting in the development and certification of Medical Related Devices.
Increased QVH potential with "undocked" software supported versions for full Operating Room use allowing expansion into "Mass Tort" and Hospital "Risk" management.
Structured and received a $2 million Revolving Bank Credit Facility (interest rate was 2.16% at year end) with Wells Fargo Bank- $1.5 million available at year end.
Restructured, extended and reduced interest rate from 12% to 6% on $500,000 loan.
Early retired $200,000 of a $500,000 12% note in 2014, and retired the $300,000 balance in March 2015.
Ongoing negotiations to add two new SPIN Affiliate's in Q2 2015.
Anticipate imminent approval of patent for QVH from US Patent and Trademark Office.
QVH, Inc. retained by Florida "Mass Tort" law firm to document faulty Hip Replacement surgery in Q2 2015.
Spine Pain Management's CEO, Dr. William Donovan stated, "As mentioned above, year over year financial comparisons were negatively affected by the decision in January of 2014 to terminate our relationships with three Florida Centers and the McAllen, TX center which historically made up some 37% of past revenues. However, closing these centers and deploying our time and strong assets on rapidly modifying and deploying our now completed latest QVH, has allowed our legacy Procedure Funding to begin picking up in Q1 2015 and also gave us the opportunity to expand QVH and the legal/medical transparency it provides to a much broader section of the Medical industry.
Dr. Donovan went on to say, "In a very short time we have taken our QVH from a 'home grown --job specific" transparency technology, to what is now a tool that can be used throughout the broad spectrum of medical procedures, from non-invasive injections to major surgery. The QVH is all about transparency, which provides comfort to the patient and medical provider alike. To assist in the monumental task of full commercialization, from final design through accreditation, we retained CCS in Sept. 2014. I am pleased that Tommy Cooper, CEO of CCS will be attending today's conference call as a panelist. He will have some comments and be available for questions."
Tommy Cooper, CEO of CCS added, "Timing is everything in development and introduction of devices used in a medical environment. With legal liability a major fast rising cost to hospitals and medical practitioners, the Quad Video HALO, developed by SPIN is a much needed, robust, transparency and documentation technology whose time has come. I am both happy and proud that CCS was asked last September to assist in both validity testing and now marshalling the now completed device through regulatory testing to receive both 'Certification to Medical Safety Standards' for domestic use, and the 'CE Mark' for EU markets."
More information on Cooper Consulting Service can be found on their Company website:
http://www.cooperconsultingservice.com/
Conference Call Details
Conference Call: An investor's conference call with management will be held on Tuesday, March 31, at 4:20 p.m. (EDT). The call will be video WebCast with a short live Power Point Presentation followed by Q & A. The call may be accessed either by phone alone, which will not allow asking questions, or by phone and/or VOIP with headset after internet log-in with an on screen provided Audio Pin # which will allow verbally asking questions. Questions can also be typed into an online chat screen at any time during the presentation or Q & A period.
Access to the Call: To use the internet link, you must register prior to access. So we suggest you complete the registration and get your log-in information in advance of the start of the presentation. You can register at any time. As mentioned above, the call is Tuesday, March 31, at 4:20 p.m. (EDT).
Click or paste the link below in your browser for registration and web access to the presentation and follow the online instructions:
https://attendee.gotowebinar.com/register/4257906422951513602
Or if the above link doesn't work, please try the following:
http://www.joinwebinar.com Webinar ID: 130-841-395
Telephone Dial-in and/or VOIP which provides Q&A: To verbally ask a question using your telephone, you must be online at the presentation website during the internet presentation where a unique Audio PIN # will be provided to you on screen after you log-in to the presentation console. You must use the pin to hear the call on the phone. During the presentation, all will be muted until the Q&A portion.
The Q & A will be moderated, but without an operator, and will be open to all questions after the formal presentations. Review this short YouTube tutorial video for pointers on how to use the Webinar Features. (This is just a demo. Do not use the numbers or codes on this demo. Use what is provided above.)
YouTube webinar instructions: http://youtu.be/n7b1VHDwwD4
If you use the telephone, but are NOT also online, you will be able to hear the presentation plus Q & A, but will remain in "listen only" mode for the duration of the call.
Conference Dial-in Number: 1 (415) 655-0059
Participant Access Code: 630-481-343
Conference Play Back: A video replay of the conference call presentation will be available several hours after the completion of the call at the company website:
http://www.spinepaininc.com/investor-information.php
About Spine Pain Management, Inc:
We are a medical services and technology company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. We deliver turnkey solutions to spine surgeons, orthopedic surgeons and other healthcare providers that provide necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Our care management services help reduce the financial burden on healthcare providers that provide patients with early-stage diagnostic testing and non-invasive surgical care, preventing many patients from being unnecessarily delayed or inhibited from obtaining needed treatment. We believe that our services and technology brings strong transparency and impartiality to all parties involved in the settlement of patient cases.
In addition, we are the owners and developers of the Quad Video HALO™, the latest hardware/software advancement in providing video transparency to medical procedures using C-Arm Fluoroscopy.
Additional information about the company, along with a video can be found at its website at www.spinepaininc.com.
SPIN has spun out of control.. BS starts soon..
Spine Pain Management Reports 2014 Financial Results and Reminds for Conference Call at 4:20 EDT Today
HOUSTON, March 31, 2015 (GLOBE NEWSWIRE) -- Spine Pain Management, Inc. (OTCQB:SPIN), a technology-driven, medical service, device and healthcare solution company servicing the multi-billion dollar spine injury sector, will hold an Investor conference call on Tuesday, March 31, at 4:20 p.m. (EDT) to discuss the Company's financial results for its full year 2014 and provide an update on its business initiatives.
For the year ended December 31, 2014 versus 2013:
We recorded $2,046,977 in net revenues with $980,811 in costs of services and gross profit of $1,066,166 for the year ended December 31, 2014. For the year ended December 31, 2013, we recorded $3,299,928 in net revenues with $1,320,348 in costs of services and gross profit of $1,979,580. Revenue was negatively affected by lower case volume in 2014 due to multiple factors. In January 2014 we made the decision to cease financing centers in Florida and terminated our affiliation with our healthcare provider in the state. This decision was made due to the state's difficult personal injury case environment, coupled with our Florida affiliate's bankruptcy (the bankruptcy court has deemed the previously issued letters of protection we obtained through this affiliate will remain our property and should be unaffected by the bankruptcy). Also in January 2014, we made the decision to discontinue doing business in McAllen, Texas in connection with increased competition in the area. We have no revenue from our Florida or McAllen affiliates for the twelve months ended December 31, 2014.
We recognize revenue by reference to "net revenue," which is gross amounts billed using CPT (Current Procedural Terminology) codes less account discounts that are expected to result when individual cases are ultimately settled. A discount rate of 52%, based on settled patient cases, was used to determine net revenue during 2014 and 2013, respectively. Accordingly, we had gross revenues of $4,239,164 with net revenues of $2,046,977 for the year ended December 31, 2014, versus gross revenues of $6,695,289 with net revenues of $3,299,928 for the year ended December 31, 2013.
Expenses
For the year ended December 31, 2014 versus 2013:
Operating, general and administrative expenses for the year ended December 31, 2014 were $2,493,555 as compared to $2,270,230 for the year ended December 31, 2013. The increase in operating expenses was primarily the result of additional overhead associated with our Quad Video marketing, development, and consulting costs.
Net Income or Loss
For the year ended December 31, 2014 versus 2013:
Net loss for the year ended December 31, 2014 was $1,692,658, or $.09 per share compared to net loss of $626,071, or $.03 per share for the year ended December 31, 2013. Lower revenue, due to closing the Florida and McAllen affiliates, coupled with additional personnel to develop and market the Quad Video Halo, resulted in net loss increasing in 2014 from 2013.
During the year ended December 31, 2014, our operations focused on continued development of our spine injury diagnostic business, coupled with the commercial development of our Quad Video Halo for sale to healthcare providers. We incurred charges in re-designing the equipment plus marketing costs for personnel. We also incurred costs in preparing our warehouse for testing of our equipment. In 2014, the operating, general and administrative costs pertaining to the Quad Video Halo totaled $405,008.
Major Developments and Milestones
1,703 Cases Settled to date with cash received surpassing $11 million; leaving 2,414 cases already funded awaiting Settlement.
To maximize potential Shareholder Value, established our patent pending, Quad Video HALO (QVH) in a wholly owned subsidiary and appointed David Spencer, lead development Consultant as President of the new subsidiary.
Opened a Development, Assembly and Warehouse Facility for QVH in Houston, Texas.
Retained Cooper Consulting (CCS), a 30 year old Houston based firm specializing in advising and assisting in the development and certification of Medical Related Devices.
Increased QVH potential with "undocked" software supported versions for full Operating Room use allowing expansion into "Mass Tort" and Hospital "Risk" management.
Structured and received a $2 million Revolving Bank Credit Facility (interest rate was 2.16% at year end) with Wells Fargo Bank- $1.5 million available at year end.
Restructured, extended and reduced interest rate from 12% to 6% on $500,000 loan.
Early retired $200,000 of a $500,000 12% note in 2014, and retired the $300,000 balance in March 2015.
Ongoing negotiations to add two new SPIN Affiliate's in Q2 2015.
Anticipate imminent approval of patent for QVH from US Patent and Trademark Office.
QVH, Inc. retained by Florida "Mass Tort" law firm to document faulty Hip Replacement surgery in Q2 2015.
Spine Pain Management's CEO, Dr. William Donovan stated, "As mentioned above, year over year financial comparisons were negatively affected by the decision in January of 2014 to terminate our relationships with three Florida Centers and the McAllen, TX center which historically made up some 37% of past revenues. However, closing these centers and deploying our time and strong assets on rapidly modifying and deploying our now completed latest QVH, has allowed our legacy Procedure Funding to begin picking up in Q1 2015 and also gave us the opportunity to expand QVH and the legal/medical transparency it provides to a much broader section of the Medical industry.
Dr. Donovan went on to say, "In a very short time we have taken our QVH from a 'home grown --job specific" transparency technology, to what is now a tool that can be used throughout the broad spectrum of medical procedures, from non-invasive injections to major surgery. The QVH is all about transparency, which provides comfort to the patient and medical provider alike. To assist in the monumental task of full commercialization, from final design through accreditation, we retained CCS in Sept. 2014. I am pleased that Tommy Cooper, CEO of CCS will be attending today's conference call as a panelist. He will have some comments and be available for questions."
Tommy Cooper, CEO of CCS added, "Timing is everything in development and introduction of devices used in a medical environment. With legal liability a major fast rising cost to hospitals and medical practitioners, the Quad Video HALO, developed by SPIN is a much needed, robust, transparency and documentation technology whose time has come. I am both happy and proud that CCS was asked last September to assist in both validity testing and now marshalling the now completed device through regulatory testing to receive both 'Certification to Medical Safety Standards' for domestic use, and the 'CE Mark' for EU markets."
More information on Cooper Consulting Service can be found on their Company website:
http://www.cooperconsultingservice.com/
Conference Call Details
Conference Call: An investor's conference call with management will be held on Tuesday, March 31, at 4:20 p.m. (EDT). The call will be video WebCast with a short live Power Point Presentation followed by Q & A. The call may be accessed either by phone alone, which will not allow asking questions, or by phone and/or VOIP with headset after internet log-in with an on screen provided Audio Pin # which will allow verbally asking questions. Questions can also be typed into an online chat screen at any time during the presentation or Q & A period.
Access to the Call: To use the internet link, you must register prior to access. So we suggest you complete the registration and get your log-in information in advance of the start of the presentation. You can register at any time. As mentioned above, the call is Tuesday, March 31, at 4:20 p.m. (EDT).
Click or paste the link below in your browser for registration and web access to the presentation and follow the online instructions:
https://attendee.gotowebinar.com/register/4257906422951513602
Or if the above link doesn't work, please try the following:
http://www.joinwebinar.com Webinar ID: 130-841-395
Telephone Dial-in and/or VOIP which provides Q&A: To verbally ask a question using your telephone, you must be online at the presentation website during the internet presentation where a unique Audio PIN # will be provided to you on screen after you log-in to the presentation console. You must use the pin to hear the call on the phone. During the presentation, all will be muted until the Q&A portion.
The Q & A will be moderated, but without an operator, and will be open to all questions after the formal presentations. Review this short YouTube tutorial video for pointers on how to use the Webinar Features. (This is just a demo. Do not use the numbers or codes on this demo. Use what is provided above.)
YouTube webinar instructions: http://youtu.be/n7b1VHDwwD4
If you use the telephone, but are NOT also online, you will be able to hear the presentation plus Q & A, but will remain in "listen only" mode for the duration of the call.
Conference Dial-in Number: 1 (415) 655-0059
Participant Access Code: 630-481-343
Conference Play Back: A video replay of the conference call presentation will be available several hours after the completion of the call at the company website:
http://www.spinepaininc.com/investor-information.php
About Spine Pain Management, Inc:
We are a medical services and technology company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. We deliver turnkey solutions to spine surgeons, orthopedic surgeons and other healthcare providers that provide necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Our care management services help reduce the financial burden on healthcare providers that provide patients with early-stage diagnostic testing and non-invasive surgical care, preventing many patients from being unnecessarily delayed or inhibited from obtaining needed treatment. We believe that our services and technology brings strong transparency and impartiality to all parties involved in the settlement of patient cases.
In addition, we are the owners and developers of the Quad Video HALO™, the latest hardware/software advancement in providing video transparency to medical procedures using C-Arm Fluoroscopy.
Additional information about the company, along with a video can be found at its website at www.spinepaininc.com.